Heures | Orateurs | Titre de la présentation | Résumé | Référence |
08:30 | Introduction | 110681 | ||
08:35 | Part 1 - Market analysis | 110685 | ||
08:35 | Chinese and APAC market carrying the torch of medical aesthetics recovery post-Covid | 110682 | ||
08:45 | Medical aesthetic market trends and competitive strategies | 110683 | ||
08:55 | Part 2 - Aesthetic Medicine Roundtable | 110684 | ||
09:25 | CEO, Sinclair China | 110687 | ||
09:25 | Executive Director, Haohai | 112212 | ||
09:25 | CEO, HTL Biotechnology | 110688 | ||
09:25 | R&D Director, China National Biotec Group (CNBG) | 110686 | ||
09:25 | Q&A with the audience | 110695 | ||
09:40 | Part 3 - Medical Dermatology Roundtable | 110690 | ||
10:10 | CEO, Hyphens Pharma | 110691 | ||
10:10 | Executive Director, HighLight Capital - PhD | 110693 | ||
10:10 | CEO, Maruho | 112209 | ||
10:10 | CEO, Technoderma Medicines | 110692 | ||
10:10 | CEO, Profex | 110694 | ||
10:10 | Q&A with the audience | 111593 | ||
10:25 | Conclusion | 111594 | ||